Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharmacia execs

This article was originally published in The Tan Sheet

Executive Summary

CEO Fred Hassan advises Pfizer he will not join firm's Board of Directors as vice chairman, Pfizer announces April 14. With Federal Trade Commission approval of merger of Pharmacia with Pfizer occurring the same day, Hassan says he plans to "pursue other career opportunities" later this month. Hassan is said to be a front runner for the CEO post at Schering-Plough (1"The Tan Sheet" April 7, 2003, p. 10). Separately, Pharmacia R&D President Goran Ando will leave the company to serve as CEO for UK biotech firm Celltech...

You may also be interested in...

Schering CEO Selection Being Closely Watched By Investors

Schering-Plough's appointment of a new CEO, following the retirement of Richard Kogan later this month, could steady the firm's share price and help it weather what is expected to be a difficult year

Does Polivy Provide A Cure For DLBCL? Too Early To Say, Argue NICE Experts

Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.

Back With A Bang: ‘Brexit Bill’ For UK’s Medical Devices Due For 2nd Reading On 2 March

Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts